Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 26]
PHARMAC funds new treatment for multiple sclerosis
Tuesday, 22 November 2005, 11:37 am | PHARMAC
A new treatment for multiple sclerosis will be funded from 1 December, Government drug-funder PHARMAC announced today. More >>
Two new treatments funded for Parkinson’s disease
Thursday, 27 October 2005, 1:17 pm | PHARMAC
Two new treatments will be subsidised from 1 November for people with Parkinson’s disease, government drug-funder PHARMAC announced today. More >>
Asthma patients to breathe easier
Thursday, 20 October 2005, 11:28 am | PHARMAC
Government drug-funder PHARMAC has announced a decision to widen access to salmeterol (Serevent) asthma inhalers, one of the group of treatments known as long-acting beta agonists (LABAs). These are used by people whose asthma is not adequately controlled ... More >>
More people to get transplant drug
Thursday, 29 September 2005, 11:16 am | PHARMAC
People who have had kidney or heart transplants will be able to have ongoing access to the anti-rejection drug mycophenolate from 1 October, Government drug-funder PHARMAC announced today. More >>
Alendronate to be subsidised
Tuesday, 27 September 2005, 12:26 am | PHARMAC
Many more people with osteoporosis will be able to have subsidised access to alendronate from 1 October 2005. More >>
Injection to aid treatment of mental illness
Thursday, 8 September 2005, 12:46 am | PHARMAC
Patients living with psychoses will have a new funded treatment option from 1 October 2005, with PHARMAC’s decision to list the injectable form of the antipsychotic medicine risperidone. More >>
Pfizer report reveals drug company agenda
Tuesday, 30 August 2005, 5:23 pm | PHARMAC
A report issued today reveals the drug industry wants patients to pay more for their drugs, and for services such as elective surgery to be cut. More >>
GP prescribing gives easier access to two drugs
Monday, 15 August 2005, 2:39 pm | PHARMAC
Changes to access criteria by drug funding agency PHARMAC will see the antidepressant venlafaxine (Efexor XR) and the anti-fungal treatment terbinafine (Lamisil) able to be prescribed by general practitioners. More >>
One step means less paperwork for cholesterol drug
Monday, 8 August 2005, 11:12 am | PHARMAC
Government drug-funder PHARMAC is giving patients easier long-term access to the cholesterol-lowering drug atorvastatin (Lipitor) and reducing the workload of clinicians in the process. More >>
Easier access to glaucoma drops
Thursday, 4 August 2005, 3:04 pm | PHARMAC
People with the progressive eye disease glaucoma will find it easier to obtain eye drops under changes being made by PHARMAC. More >>
Diabetes treatment more widely available
Monday, 1 August 2005, 10:08 am | PHARMAC
Government drug funder PHARMAC is giving more people the chance to have the new generation diabetes treatment pioglitazone (Actos). More >>
PHARMAC welcomes increased budget for 2006 year
Tuesday, 26 July 2005, 5:26 pm | PHARMAC
PHARMAC Chief Executive Wayne McNee has welcomed the approval of an increase in government pharmaceutical funding for the 2006 financial year. More >>
New pain treatment subsidised for New Zealanders
Thursday, 21 July 2005, 7:31 pm | PHARMAC
PHARMAC is further expanding the range of subsidised painkillers by subsidising a new drug, oxycodone. More >>
Advances in subsidised breast cancer treatment
Monday, 11 July 2005, 10:25 am | PHARMAC
New generation hormonal drugs are to be subsidised for some women with early breast cancer from 1 August 2005. More >>
$18m to help relieve neuropathic pain
Thursday, 23 June 2005, 11:31 am | PHARMAC
PHARMAC is committing more than $18 million over the next three years to provide gabapentin to people with severe neuropathic pain. More >>
Two steps forward for HIV treatment
Monday, 13 June 2005, 10:18 am | PHARMAC
PHARMAC will widen access to the combination HIV/AIDS treatment Kaletra (lopinavir with ritonavir). The decision follows a commitment by PHARMAC to review access to Kaletra within six months of its initial listing. More >>
Two salbutamol brands to remain funded – Pharmac
Wednesday, 8 June 2005, 9:58 am | PHARMAC
People will continue to have a choice of funded brands for salbutamol asthma inhalers, Government drug-funding agency PHARMAC announced today. More >>
PHARMAC plan to secure haemophilia treatment
Tuesday, 7 June 2005, 10:25 am | PHARMAC
PHARMAC has been given the thumbs up for securing long-term supply of products used in the treatment of haemophilia. More >>
More research into impact of dispensing
Tuesday, 31 May 2005, 2:57 pm | PHARMAC
PHARMAC is welcoming the recommendation of the Office of the Auditor General (OAG) to commission research looking at the impact of dispensing rates on medicine usage. More >>
Antibiotic resistance still growing
Thursday, 26 May 2005, 11:33 am | PHARMAC
Some bacteria are becoming resistant to a number of antibiotics at a concerning rate, according to figures from ESR, Institute of Environmental Science and Research. More >>
